Acrivon Therapeutics Inc
ACRV
NASDAQ
Biotechnology
$1.95
USD
+0.10 (+5.41%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $74.48M
Volume 752.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CRDF | Cardiff Oncology Inc | $79.39M | - | -10.7% | - | |
ATRA | Atara Biotherapeutics Inc | $76.14M | - | -88.4% | - | |
ACET | Adicet Bio Inc | $75.92M | - | - | - | |
ACRV | Acrivon Therapeutics Inc | $74.48M | - | - | - | |
ELTX | Elicio Therapeutics Inc | $72.75M | - | -91.9% | - | |
CYPH | Cypherpunk Technologies Inc | $72.41M | - | - | - | |
SPRO | Spero Therapeutics Inc | $72.09M | 4.73 | +37.2% | - | |
IBIO | iBio Inc | $70.05M | - | -20.0% | - | |
CTOR | Citius Oncology Inc | $68.57M | - | - | - | |
RNTX | Rein Therapeutics Inc | $66.05M | - | - | - |
Top Peer by Growth
Rallybio Corp
+1.2% YoY Revenue
Best 1-Year Return
Rallybio Corp
+296.3% Return